CVE-2026-9844 Details
Description
Use of default credentials vulnerability in Roche Diagnostics navify Digital Pathology (RabbitMQ Management interface modules) allows Default Usernames and Passwords. This issue affects navify Digital Pathology: from 2.0.0 before 2.4.1.
A vulnerability exists in Roche Diagnostics navify Digital Pathology, specifically within the RabbitMQ Management interface modules, due to the use of default credentials. This issue affects navify Digital Pathology versions 2.0.0 prior to 2.4.1.
Metrics
CVSS 4.0 Severity and Vector Strings:
CVSS 3.x Severity and Vector Strings:
No data available for CVSS Version 2.0 on this CVE.
Volerion
Assessed Jun 2, 2026CISA-ADP
Assessed Jun 2, 2026References to Advisories, Solutions, and Tools
By selecting these links, you will be leaving this site. These are references gathered from the official CVE record and are not endorsed by Volerion.
| URL | Source(s) | Tag(s) |
|---|---|---|
| https://diagnostics.roche.com/global/en/legal/product-security-advisory.html | Roche Diagnostics | Vendor |
Weakness Enumeration
| CWE-ID | CWE Name | Source |
|---|---|---|
| CWE-1392 | Use of Default Credentials | Roche Diagnostics |
Affected Products
| Product | Versions |
|---|---|
| Roche Diagnostics navify Digital Pathology | >= 2.0.0, < 2.4.1 (semver) |
CPE
Remediation
| |
Change History
4 change records found show changes
| Date | Action | Recorded By |
|---|---|---|
| Jul 22, 2026 | CVE Translated | [email protected] |
| Jun 17, 2026 | CVE Modified | Roche Diagnostics |
| Jun 17, 2026 | CVE Modified | CISA-ADP |
| Jun 2, 2026 | New CVE Received | Roche Diagnostics |
Volerion